KCG
AZN icon

Knight Capital Group’s AstraZeneca AZN Stock Holding History

Knight Capital Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$2.54M Buy
+53,779
New +$2.74M 0.05% 405

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Knight Capital Group's AZN Position: Q2 2013 in Review

Knight Capital Group opened a new position in AstraZeneca (AZN) in Q2 2013: 53,779 shares worth $2.54M. The stake represents 0.05% of the portfolio and ranks #405 among its holdings.

331 funds tracked by Wall St. Rank hold AZN as of Q2 2013.

  • Knight Capital Group held 53,779 shares of AstraZeneca worth $2.54M as of Q2 2013.
  • AstraZeneca was a new Knight Capital Group position in Q2 2013.
  • AstraZeneca made up 0.05% of Knight Capital Group's portfolio in Q2 2013, its #405 holding.
  • 331 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.